These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 50893)

  • 1. [Prostatic hypertrophy].
    Ito Y; Yamanaka H; Shida K
    Horumon To Rinsho; 1975 Apr; 23(4):313-21. PubMed ID: 50893
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of hormonal factors in the pathogenesis of prostatic hypertrophy].
    Baranowska B; Migdalska B; Szymanowski J; Kozłowicz I
    Pol Tyg Lek; 1977 Feb; 32(6):251-3. PubMed ID: 65771
    [No Abstract]   [Full Text] [Related]  

  • 3. Transient hypertrophy of the ventral prostate and coagulating glands and accelerated thymic involution following pinealectomy in the mouse.
    Vaughan MK; Reiter RJ
    Tex Rep Biol Med; 1971; 29(4):579-86. PubMed ID: 4113015
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is there a hormonal etiology in prostatic hypertrophy?].
    Robel P
    Ann Urol (Paris); 1985; 19(3):151-2. PubMed ID: 2411205
    [No Abstract]   [Full Text] [Related]  

  • 5. The pathogenesis of BPH: role of hormones.
    Griffiths K; Eaton CL
    Prog Clin Biol Res; 1994; 386():33-41. PubMed ID: 7528401
    [No Abstract]   [Full Text] [Related]  

  • 6. Common characteristics of human and canine benign prostatic hyperplasia.
    Isaacs JT
    Prog Clin Biol Res; 1984; 145():217-34. PubMed ID: 6201876
    [No Abstract]   [Full Text] [Related]  

  • 7. Pressure effects on cellular systems: is there a link with benign prostatic hyperplasia?
    Hegarty P; Watson RW; Hegarty NJ; Coffey RN; Fitzpatrick JM
    Urology; 2004 Aug; 64(2):195-200. PubMed ID: 15302460
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mode of hypertrophy and hyperplasia of the accessory sex glands in male rats treated with androgens].
    Kurematsu Y
    Zasshi Tokyo Ika Daigaku; 1967 Jul; 25(3):347-60. PubMed ID: 4171328
    [No Abstract]   [Full Text] [Related]  

  • 9. Human benign prostatic hyperplasia: etiological considerations.
    Walsh PC
    Prog Clin Biol Res; 1984; 145():1-25. PubMed ID: 6201871
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenesis of prostatic hyperplasia and neoplasia.
    Roberts HJ
    Geriatrics; 1967 Dec; 22(12):85-92. PubMed ID: 4168607
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathogenesis and norsteroid treatment of bladder neck adenoma (prostatic hypertrophy)].
    Magyarsóky F
    Acta Chir Acad Sci Hung; 1973 Aug; 14(3):209-22. PubMed ID: 4129777
    [No Abstract]   [Full Text] [Related]  

  • 12. Etiology of benign prostatic hyperplasia.
    Lee C; Kozlowski JM; Grayhack JT
    Urol Clin North Am; 1995 May; 22(2):237-46. PubMed ID: 7539172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumorous prostatic diseases. I. Prostatic adenoma--genesis, clinical aspects, therapy].
    Reichelt H
    Z Allgemeinmed; 1974 May; 50(15):688-93. PubMed ID: 4137484
    [No Abstract]   [Full Text] [Related]  

  • 14. Benign prostatic hyperplasia due to venous drainage malfunction in the male reproductive system: a price of erect posture in humans.
    Schill WB; Ben-Shlomo I
    Andrologia; 2008 Oct; 40(5):272. PubMed ID: 18811915
    [No Abstract]   [Full Text] [Related]  

  • 15. Benign prostatic hyperplasia. Current strategy and pharmacotherapeutical potential.
    Dutkiewicz S
    Mater Med Pol; 1995; 27(1):3-6. PubMed ID: 8569274
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality of life, voiding symptoms and uroflowmetry in healthy males and benign prostatic hyperplasia (BPH) patients.
    Batista JE; Regalado R; Araño P; Vicente J
    J Urol (Paris); 1995; 101(1):3-6. PubMed ID: 7545724
    [No Abstract]   [Full Text] [Related]  

  • 17. [Epidemiology and natural history of benign prostatic hyperplasia].
    Sugimura Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():318-21. PubMed ID: 12599592
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormonal treatment of prostatic hypertrophy with special reference to the usefulness of gestagens].
    Musierowicz A
    Wiad Lek; 1974 Nov; 27(22):1985-8. PubMed ID: 4140619
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prostatic hypertrophy].
    Kontturi M
    Duodecim; 1989; 105(10):886-93. PubMed ID: 2475321
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prostatic hypertrophy as an example of a true disposition with age].
    Schinz HR; Reich T
    Acta Iber Radiol Cancerol; 1966; 21(77):259-65. PubMed ID: 4171544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.